Erika Schultz | executive |
John Jacobs | executive |
James Kelly | executive |
John Trizzino | executive |
Filip Dubovsky | executive |
Jiale Song | analyst |
Eric Joseph | analyst |
Mayank Mamtani | analyst |
Brendan Smith | analyst |
Vernon Bernardino | analyst |
Good morning, and welcome to Novavax' First Quarter 2024 Financial Results and Operational Highlights Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Erika Schultz, Senior Director, Investor Relations. Please go ahead.
Good morning, and thank you all for joining us today to discuss our first quarter 2024 financial results and operational highlights.